ArticleCase reports in oncology

Pralatrexate for Prolonged Treatment of Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified, with Prophylactic Leucovorin.

Koichi Kitazume et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.